Text Size

The Prevalence of Metabolic Syndrome in Patients Suffering From Chronic Pain

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2009 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT00885261
First received: April 19, 2009
Last updated: October 31, 2011
Last verified: April 2009
History of Changes
  Purpose

Obesity is considered as the epidemic of the century. Central obesity is one of the metabolic syndrome's features. It has been proven that obesity can cause back pain and headaches; thus, there might be a link between chronic pain and the syndrome.

The objective of this study is to assess the prevalence of metabolic syndrome in patients suffering from chronic pain.


Condition
Pain and Metabolic Syndrome

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Prevalence of Metabolic Syndrome in Patients Suffering From Chronic Pain

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Estimated Enrollment: 100
Study Start Date: May 2009
Estimated Study Completion Date: April 2012
Detailed Description:

All patients will answer a questionnaire, their hip circumference will be measured, and their BMI will be calculated (weight/(height)2 ).

The patients' blood pressure will be measured. The patients will be asked to bring their blood tests (lipids and glucose).

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients over 18 that suffer from chronic pain and are being treated at the pain medicine unit

Criteria

Inclusion Criteria:

  • Patients over 18 that suffer from chronic pain and are being treated at the pain medicine unit

Exclusion Criteria:

  • Pregnant women, patients with abdominal wall defects
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00885261

Locations
Israel
Pain Medicine Unit Recruiting
Tel Aviv, Israel
Contact: silviu Brill, M.D     972-3-6974477     silviub@tasmc.health.gov.il    
Principal Investigator: Silviu Brill, M.D            
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Principal Investigator: Silviu Brill, MD Tel-Aviv Sourasky Medical Center
  More Information

No publications provided

Responsible Party: Silviu Brill MD, Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier: NCT00885261     History of Changes
Other Study ID Numbers: TASMC-09-SB-096-CTIL
Study First Received: April 19, 2009
Last Updated: October 31, 2011
Health Authority: Israel: Ethics Commission

Keywords provided by Tel-Aviv Sourasky Medical Center:
chronic pain and metabolic syndrome

Additional relevant MeSH terms:
Metabolic Syndrome X
Stress, Psychological
Insulin Resistance
Hyperinsulinism
 Glucose Metabolism Disorders
Metabolic Diseases
Behavioral Symptoms

ClinicalTrials.gov processed this record on June 17, 2013